KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Convertible Debt: 2020-2025

Historic Convertible Debt for Neogenomics (NEO) over the last 6 years, with Sep 2025 value amounting to $341.5 million.

  • Neogenomics' Convertible Debt rose 0.45% to $341.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $341.5 million, marking a year-over-year increase of 0.45%. This contributed to the annual value of $340.3 million for FY2024, which is 36.76% down from last year.
  • Neogenomics' Convertible Debt amounted to $341.5 million in Q3 2025, which was up 0.11% from $341.1 million recorded in Q2 2025.
  • In the past 5 years, Neogenomics' Convertible Debt registered a high of $538.9 million during Q1 2024, and its lowest value of $339.6 million during Q2 2024.
  • For the 3-year period, Neogenomics' Convertible Debt averaged around $430.0 million, with its median value being $341.5 million (2025).
  • As far as peak fluctuations go, Neogenomics' Convertible Debt spiked by 222.76% in 2021, and later tumbled by 36.78% in 2025.
  • Quarterly analysis of 5 years shows Neogenomics' Convertible Debt stood at $532.5 million in 2021, then increased by 0.53% to $535.3 million in 2022, then increased by 0.54% to $538.2 million in 2023, then slumped by 36.76% to $340.3 million in 2024, then increased by 0.45% to $341.5 million in 2025.
  • Its Convertible Debt stands at $341.5 million for Q3 2025, versus $341.1 million for Q2 2025 and $340.7 million for Q1 2025.